Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus

Roman, Mary J., Crow, Mary K., Lockshin, Michael D., Devereux, Richard B., Paget, Stephen A., Sammaritano, Lisa, Levine, Daniel M., Davis, Adrienne, Salmon, Jane E.·2007·Arthritis & Rheumatism

Abstract

Objective: To determine the rate of atherosclerosis progression as well as the relationship of traditional risk factors, systemic lupus erythematosus (SLE)–related factors, and treatment to atherosis progression in SLE patients. Methods: Outpatients in the Hospital for Special Surgery SLE Registry underwent serial carotid ultrasound and clinical assessment in a longitudinal study. Results: Among 158 patients, 77 (49%) had persistent absence of atherosclerosis (carotid plaque), 36 (23%) had unchanged atherosclerosis, and 45 (28%) had progressive atherosclerosis, defined as a higher plaque score (new plaque in 25 patients and more extensive plaque in 20 patients) after a mean ± SD interval of 34 ± 9 months. Multivariate determinants of atherosclerosis progression were age at diagnosis (odds ratio [OR] 2.75, 95% confidence interval [95% CI] 1.67–4.54 per 10 years, P < 0.001), duration of SLE (OR 3.16, 95% CI 1.64–6.07 per 10 years, P < 0.001), and baseline homocysteine concentration (OR 1.24, 95% CI 1.06–1.44 per μmoles/liter, P = 0.006). SLE patients with stable plaque and progressive plaque differed only in baseline homocysteine concentration. Atherosclerosis progression was increased across tertiles of homocysteine concentration (16.2%, 36.4%, and 56.1%; P = 0.001), and homocysteine tertile was independently related to progression of atherosclerosis (OR 3.14, 95% CI 1.65–5.95 per tertile, P < 0.001). Less aggressive immunosuppressive therapy and lower average prednisone dose were associated with progression of atherosclerosis in univariate, but not multivariate, analyses. Inflammatory markers and lipids were not related to atherosclerosis progression. Conclusion: Atherosclerosis develops or progresses in a substantial minority of SLE patients during short‐term followup (10% per year on average). Older age at diagnosis, longer duration of SLE, and higher homocysteine concentration are independently related to progression of atherosclerosis. These findings show that aggressive control of SLE and lowering of homocysteine concentrations are potential means to retard the development and progression of atherosclerosis in SLE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.22924

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 196

Metadata

Authors
Roman, M. J., Crow, M. K., Lockshin, M. D., Devereux, R. B., Paget, S. A., Sammaritano, L., Levine, D. M., Davis, A., & Salmon, J. E.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2007-09-28
Volume
56
Issue
10
Pages
3412-3419
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2014530534
Cited by
196
References
6
FWCI
8.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. https://app.cochat.ai/papers/10.1002/art.22924
The paper
Roman, M. J., Crow, M. K., Lockshin, M. D., Devereux, R. B., Paget, S. A., Sammaritano, L., Levine, D. M., Davis, A., & Salmon, J. E. (2007). Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis & Rheumatism. https://doi.org/10.1002/art.22924

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.